| Financial Year |
March 31 2023 |
| Monetary Funds |
722,074,896.69 |
| Held-for-trading Financial Assets |
1,355,896,549.10 |
| Notes Receivable |
-- |
| Accounts Receivable |
227,877,583.61 |
| Advances to Suppliers |
81,139,094.51 |
| Other Receivables |
23,175,784.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
432,014,127.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,459,515.31 |
| Total Current Assets |
2,848,637,551.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
218,537,211.84 |
| Investment Properties |
-- |
| Fixed Assetes |
1,101,438,777.13 |
| Under-construction Projects |
120,119,499.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
195,153,090.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,277,638.80 |
| Deferred Income Tax Assets |
68,349,300.09 |
| Other Non-Current Assets |
2,579,283.50 |
| Sub-Total of Non-Current Assets |
1,750,163,941.31 |
| Total Assets |
4,598,801,492.80 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
347,948,984.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
47,906,081.85 |
| Taxes Payable |
139,613,698.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
103,806,463.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,885,725.40 |
| Other Current Liabilities |
21,263,204.20 |
| Sub-Total of Current Liabilities |
747,809,513.55 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
16,988,116.16 |
| Deferred Income Tax Liabilities |
3,386,897.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
102,548,823.32 |
| Total Liabilities |
850,358,336.87 |
| Paid-In Capital(Or Share Stock) |
435,600,000.00 |
| Capital Surplus |
691,421,353.35 |
| Surplus Reserve |
217,800,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,403,621,802.58 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,748,443,155.93 |
| Owner's Equity（Stockholder's Equity） |
3,748,443,155.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,598,801,492.80 |
